[PDF] Top 20 Pharmacoeconomics applied to chronic hepatitis C

... of chronic hepatitis C with the combination of peginterferon alfa- 2a (40KD) and ribavirin versus the combination of conventional interferon and ...of hepatitis C) in monetary units was ... See full document

... matitis reaction affecting more than 50% of body surface but with no signs of SJS, TEN, DRESS, EM or AGEP, may be manageable using topical corticosteroids without treatment discontinuation. In such cases, hospitalization ... See full document

... corresponding to the HBV polymerase gene, targeted to the region of mutations associated with lamivudine resistance. Serum samples were denatured and neutralized as described above and submitted to ... See full document

... related to the progression of HCV ...led to several inconsistencies and controversies, including the possible correlation between serum protein levels and disease outcomes in chronic viral ... See full document

... of hepatitis C virus (HCV) has clinical importance due to genotype 1 lower response to treatment compared with genotypes 2 and ...was to describe clinical and laboratorial profiles of ... See full document

... were to assess the in vitro-induced anti-hepatitis C virus (HCV) antibody production (IVIAP) in relation to the clinical, biochemical, virologic and histologic variables of patients with HCV ... See full document

... Statistical analysis was performed by Analyse-it software for Microsoft Excel. Descriptive results were expressed as mean ± standard deviation (SD) or number (percentage) of patients with a condition. The ANOVA one-way ... See full document

... Chronic hepatitis C virus (HCV) infection is now the most important cause of liver cirrhosis and hepatocellular carcinoma ...was to evaluate efficacy and safety of the treatment with ... See full document

... used to determine whether continuous variables showed a normal ...were applied to compare numerical ...performed to identify variables that were independently associated with ... See full document

... with chronic hepatitis C genotype 1 is near to the reported mean prevalence of 55%, with range of 38% to 80% (11, 12, ...results to the other authors, we also found the ... See full document

... with chronic C hepatitis; however, this association remains without statistical or causal ...with chronic hepatitis C will be described, with subcutaneous lesions, considered ... See full document

... tantly to a large number of hepatitis C carriers and some epidemiological risk scenarios are coincident for both ...for hepatitis C in reference centers in Brazil between 2001 and 2012 ... See full document

... assumed to measure a similar ...intended to explore the level of difficulty in executing physical activities and limitations or less activity accomplishments, ...able to accomplish activities due ... See full document

... susceptible to develop this complication. This correlation adds a new variable to be evaluated in the studies of MC prevalence in hepatitis ... See full document

... Occult hepatitis B virus (HBV) infections have been identified in patients with chronic hepatitis C virus (HCV) infection, although the clinical relevance of occult HBV infection remains ... See full document

... useful to derive the 8 health SF-36 sub- scales to gather more detailed clinical data for meaningful ...pertained to the presen- tation of continuous data from skewed distributions as mean and SD ... See full document

... seeks to assess adherence, adverse drug reaction and Sustained Virological Response (SVR) in the therapy for he- patitis ...for hepatitis treatment in Southern ...under hepatitis C treatment ... See full document

... agreed to participate in the study after reading and signing the informed ...prior to inclusion in the study or previous antiviral ...for hepatitis B surface antigen and anti-human immunodeficiency ... See full document

... Thirty-five patients were analyzed. There was a light predom- inance of females 19 (54.3 %), the mean age was 52.1 ± 10.1 years (34–70 years), 32 (91.4 %) were previously submitted to renal transplants and 3 (8.6 ... See full document

... with chronic hepatitis C after treatment and the ideal follow-up time for these patients remains unde- fi ...was to evaluate the durability of the virologic response in patients with ... See full document